---
figid: PMC5685773__oncotarget-08-90545-g002
figtitle: Melatonin as a potential inhibitory agent in head and neck cancer
organisms:
- Nicotiana tabacum
- PX clade
- Rubus idaeus
- Leucaena leucocephala
- Bos taurus
- Ovis aries
- Sus scrofa domesticus
- Gallus gallus
- Turdus migratorius
- Homo sapiens
- Mus musculus
pmcid: PMC5685773
filename: oncotarget-08-90545-g002.jpg
figlink: /pmc/articles/PMC5685773/figure/F2/
number: F2
caption: Melatonin treatment reduces HNSCC cell metastasis through inhibiting the
  expression of MMP-9 by targeting the ERK/JNK signal pathway to mediate histone acetylation
  and SP-1 expression. Melatonin inhibits HNSCC cell proliferation through upregulating
  p38, H2AX and p53 expression and downregulating the expression of hnRNPA1 and mir-24.
  Melatonin supplementation suppresses NHSCC cells angiogenesis by reducing the expression
  of angiogenesis molecular markers, HIF-1α and VEGF. ERK, mitogen-activated protein
  kinase; JNK, c-Jun N-terminal kinase; MMP-9, matrix metalloproteinase 9; H2AX, H2A
  histone family member X; hnRNPA1, heterogeneous nuclear ribonucleoprotein A1; HIF-1α,
  hypoxia inducible factor 1 alpha subunit; VEGF, vascular endothelial growth factor.
papertitle: Melatonin as a potential inhibitory agent in head and neck cancer.
reftext: Chia-Ming Yeh, et al. Oncotarget. 2017 Oct 27;8(52):90545-90556.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9500596
figid_alias: PMC5685773__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Gallus gallus
- Ovis aries
- Bos taurus
redirect_from: /figures/PMC5685773__F2
ndex: 5a932b6c-dee6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5685773__oncotarget-08-90545-g002.html
  '@type': Dataset
  description: Melatonin treatment reduces HNSCC cell metastasis through inhibiting
    the expression of MMP-9 by targeting the ERK/JNK signal pathway to mediate histone
    acetylation and SP-1 expression. Melatonin inhibits HNSCC cell proliferation through
    upregulating p38, H2AX and p53 expression and downregulating the expression of
    hnRNPA1 and mir-24. Melatonin supplementation suppresses NHSCC cells angiogenesis
    by reducing the expression of angiogenesis molecular markers, HIF-1α and VEGF.
    ERK, mitogen-activated protein kinase; JNK, c-Jun N-terminal kinase; MMP-9, matrix
    metalloproteinase 9; H2AX, H2A histone family member X; hnRNPA1, heterogeneous
    nuclear ribonucleoprotein A1; HIF-1α, hypoxia inducible factor 1 alpha subunit;
    VEGF, vascular endothelial growth factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Hc
  - Hnrnpa1
  - Ephb2
  - Mapk1
  - Mapk8
  - Mir24-1
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Sp1
  - Trp53
  - Mmp9
  - Hif1a
  - Vegfa
  - HNRNPA1
  - HNRNPA3
  - MIR24-2
  - CRK
  - SP1
  - MMP9
  - HIF1A
  - VEGFA
  - TP53
  - MAPK14
---
